Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1985
Qualitative erythrocyte enzymatic disorder in Ehrlich tumor-bearing mice
O C Barretto, S B Zyngier
Journal of Cancer Research and Clinical Oncology
|
January 1, 1984
Acquired disturbance of erythrocyte glutathione reductase in experimental tumors
O C Barretto, S B Zyngier
Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 1, 1975
[Biological determination of anti-cholinesterasic substances (author's transl)]
Z B Fortes, D Nigro, S B Zyngier
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 18, 1979
Anti-inflammatory effect of warfarin and vitamin K1
F W Eichbaum, O Slemer, S B Zyngier
Revista Paulista De Medicina
|
March 1, 1985
[Hemostatic changes in several experimental tumors]
S B Zyngier, O C Barretto, E Coelho, et al.
Journal of Inorganic Biochemistry
|
October 1, 1996
Water-soluble rhodium(II) carboxylate adducts: cytotoxicity of the new compounds
A R de Souza, R Najjar, S Glikmanas, et al.
Metal-Based Drugs
|
January 1, 1997
Distribution of rhodium in mice submitted to treatment with the adduct of rhodium propionate and sodium isonicotinate
A R de Souza, R Najjar, E de Oliveira, et al.
Metal-Based Drugs
|
January 1, 1997
Rh(2)(CF(3)CONH)(4): The First Biological Assays of a Rhodium (II) Amidate
B P Espósito, S B Zyngier, A R de Souza, et al.
Metal-Based Drugs
|
May 14, 2008
Water Soluble Cyclophosphamide Adducts of Rhodium(II) Keto-Gluconate and Glucuronate. Synthesis, Characterization and In Vitro Cytostatic Assays
E de S Gil, M I Gonçalves, E I Ferreira, et al.
Metal-Based Drugs
|
May 14, 2008
Survival and Histopathological Study of Animals Bearing Ehrlich Tumor Treated With a Rhodium(II) Amidate
B P Espósito, S B Zyngier, R Najjar, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Cancer Research and Clinical Oncology
|
January 1, 1985
Qualitative erythrocyte enzymatic disorder in Ehrlich tumor-bearing mice
O C Barretto, S B Zyngier
Journal of Cancer Research and Clinical Oncology
|
January 1, 1984
Acquired disturbance of erythrocyte glutathione reductase in experimental tumors
O C Barretto, S B Zyngier
Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 1, 1975
[Biological determination of anti-cholinesterasic substances (author's transl)]
Z B Fortes, D Nigro, S B Zyngier
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 18, 1979
Anti-inflammatory effect of warfarin and vitamin K1
F W Eichbaum, O Slemer, S B Zyngier
Revista Paulista De Medicina
|
March 1, 1985
[Hemostatic changes in several experimental tumors]
S B Zyngier, O C Barretto, E Coelho, et al.
Journal of Inorganic Biochemistry
|
October 1, 1996
Water-soluble rhodium(II) carboxylate adducts: cytotoxicity of the new compounds
A R de Souza, R Najjar, S Glikmanas, et al.
Metal-Based Drugs
|
January 1, 1997
Distribution of rhodium in mice submitted to treatment with the adduct of rhodium propionate and sodium isonicotinate
A R de Souza, R Najjar, E de Oliveira, et al.
Metal-Based Drugs
|
January 1, 1997
Rh(2)(CF(3)CONH)(4): The First Biological Assays of a Rhodium (II) Amidate
B P Espósito, S B Zyngier, A R de Souza, et al.
Metal-Based Drugs
|
May 14, 2008
Water Soluble Cyclophosphamide Adducts of Rhodium(II) Keto-Gluconate and Glucuronate. Synthesis, Characterization and In Vitro Cytostatic Assays
E de S Gil, M I Gonçalves, E I Ferreira, et al.
Metal-Based Drugs
|
May 14, 2008
Survival and Histopathological Study of Animals Bearing Ehrlich Tumor Treated With a Rhodium(II) Amidate
B P Espósito, S B Zyngier, R Najjar, et al.
Page
of 2